drugset / Trial / NCT00299858

Theophylline in Chronic Obstructive Pulmonary Disease

NCT00299858

RandomizedParallel-groupDouble-blindTreatment

Summary

This will be a prospective randomized double-blinded parallel group clinical trial evaluating the short-term effects of theophylline therapy on exercise duration and lung function in patients with chronic obstructive pulmonary disease already receiving both tiotropium and a long-acting beta-agonist (salmeterol or formoterol).

Timeline

Start
2006-10
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Theophylline Small molecule 10 mg/kg